XML 144 R127.htm IDEA: XBRL DOCUMENT v3.24.2
Note 30 - Segment Reporting - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
May 31, 2024
May 31, 2023
May 31, 2022
Net revenue $ 788,942 $ 627,124 $ 628,372
Cost of goods sold 565,591 480,164 511,555
Gross Profit 223,351 146,960 116,817
Cannabis Segment [Member]      
Net revenue 272,798 220,430 237,522
Cost of goods sold 182,594 162,755 194,834
Gross Profit 90,204 57,675 42,688
Revenue 370,692 284,314 300,891
Excise taxes (97,894) (63,884) (63,369)
Cannabis Segment [Member] | Medical Cannabis Products [Member]      
Revenue 25,211 25,000 30,599
Cannabis Segment [Member] | Adult-use Cannabis Products [Member]      
Revenue 266,846 214,319 209,501
Cannabis Segment [Member] | Wholesale Cannabis Products [Member]      
Revenue 25,340 1,436 6,904
Cannabis Segment [Member] | International Cannabis Products [Member]      
Revenue 53,295 43,559 53,887
Beverage Alcohol Business [Member]      
Net revenue 202,094 95,093 71,492
Cost of goods sold 113,522 48,770 32,033
Gross Profit 88,572 46,323 39,459
Revenue 213,614 100,679 74,959
Excise taxes (11,520) (5,586) (3,467)
Tilray Pharma Segment [Member]      
Net revenue 258,740 258,770 259,747
Cost of goods sold 230,596 231,309 243,231
Gross Profit 28,144 27,461 16,516
Wellness Business [Member]      
Net revenue 55,310 52,831 59,611
Cost of goods sold 38,879 37,330 41,457
Gross Profit $ 16,431 $ 15,501 $ 18,154